Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Biotech components
Biotech components
Microbe
Products 1 to 10 of 16
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Alternative Protein
by
Motif Ingredients
Biotech components:
Microbe
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/04/01 10:01 (6 years ago)
Date last modified:
2019/04/01 10:01 (6 years ago)
Known funding amount:
90,000,000 USD
Funding types:
Venture Capital
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Food
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Input
Bacterial Cellulose produced by Microorganisms
by
Chinese Academy of Sciences
Biotech components:
Bacteria
+
Enzyme
+
Microbe
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/02/10 09:55 (5 years ago)
Date last modified:
2020/02/10 09:55 (5 years ago)
Known funding amount:
N/A
Funding types:
Government
+
Research Institution
+
University
Industry:
Industrial
+
Medical
+
Science
Market status:
Early Stage Concept
Organization type(s):
Research Institution
+
University
Product categories:
N/A
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Platform
Bio-DEM™
by
Lygos, Inc (Advanced Biofuels Process Demonstration Unit)
Biotech components:
Enzyme
+
Gene Editing
+
Microbe
+
Plant
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 14:33 (5 years ago)
Date last modified:
2019/09/12 14:33 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
+
Venture Capital
Industry:
Industrial
+
Multipurpose
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Additive
+
Chemical
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Input
Bioengineered Salmonella enterica
by
Prokarium
Biotech components:
Microbe
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:18 (5 years ago)
Date last modified:
2019/09/12 15:18 (5 years ago)
Known funding amount:
N/A
Funding types:
N/A
Industry:
Medical
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Medical Treatment
+
Medicine
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Biologically Functional Assemblies of Robust Microenvironments (BioFARMS)
by
Caltech
Biotech components:
Microbe
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Research
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
3,498,401 USD
Funding types:
Government
Industry:
Science
Market status:
Early Stage Concept
Organization type(s):
University
Product categories:
Research
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
N/A
Value chain stage:
Platform
Micro-algae fatty acids
by
Flinders University
Biotech components:
Microbe
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:39 (4 years ago)
Date last modified:
2020/12/18 14:39 (4 years ago)
Known funding amount:
N/A
Funding types:
University
Industry:
Food & Agriculture
+
Health
Market status:
Early Stage Concept
Organization type(s):
University
Product categories:
Food
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
N/A
Microbial Fuel Cells
by
Lebônê
Biotech components:
Microbe
Business models:
B2C
Country of production:
South Africa
Country of distribution:
Namibia
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2019/05/15 15:40 (6 years ago)
Known funding amount:
300,000 USD
Funding types:
Development Bank
+
Foundation
Industry:
Industrial
Market status:
Early Stage Concept
+
No longer on the market
Organization type(s):
Private Company
Product categories:
Fuel and Energy
Production process:
Open Release
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
ON Technology
by
Pivot Bio
Biotech components:
Microbe
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/08 14:36 (6 years ago)
Known funding amount:
16,700,000 USD
Funding types:
Venture Capital
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Soil Amendment
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Pivot Bio PROVEN
by
Pivot Bio
Biotech components:
Microbe
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/02/10 10:00 (5 years ago)
Date last modified:
2020/02/10 10:00 (5 years ago)
Known funding amount:
86,700,000 USD
Funding types:
Venture Capital
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Soil Amendment
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Input
Resveratrol
by
Evolva
Biotech components:
Microbe
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
USA
+
Europe
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
86,000,000 CHF
Funding types:
Shareholder Investment
Industry:
Health
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Food
+
Personal Care (Topical)
+
Personal Care (Ingested)
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
EVE
(SWX)
Value chain stage:
Input
1
2
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
